We completed our first MGH Women’s Mental Health online CME program in the Fall of 2019, and we are excited to offer the next round of the course in the series. Thank you for those [...]
We completed our first MGH Women’s Mental Health online CME program in the Fall of 2019, and we are excited to offer the next round of the course in the series. Thank you for those [...]
This fall, we are offering an online course on women's mental health. This online course will focus on the diagnosis and treatment of psychiatric disorders in women across the reproductive lifespan. Specialized knowledge is necessary [...]
For those of you who will not be able to attend our one day course in Women’s Mental Health in Boston on Thursday, October 17th, we are offering an online version of the course. This [...]
Over the last few years, we have seen an increasing number of women with substance use disorders in our clinic. We are very excited that Dr. Edwin Raffi from the Center for Women's Mental Health [...]
According to a report published by the CDC in Morbidity and Mortality Weekly Report (MMWR), the use of stimulant medications for the treatment of attention-deficit/hyperactivity disorder (ADHD) by reproductive-age women is on the rise. In [...]
We are excited to announce that we will be offering a new one day course in Women’s Mental Health in Boston on Thursday, October 17th. This is the day preceding the Annual Psychopharmacology Conference (October [...]
We are excited to announce that we will be offering a new one day course in Women’s Mental Health in Boston on Thursday, October 17th. This is the day preceding the Annual Psychopharmacology Conference (October [...]
Analyzing data from the Swedish Medical Birth Register, the Prescribed Drug Register, and the Swedish Neonatal Quality Register, researchers compared infants exposed to ADHD medication during pregnancy with infants whose mothers never used these drugs [...]
According to a report published by the CDC in Morbidity and Mortality Weekly Report (MMWR), the use of stimulant medications for the treatment of attention-deficit/hyperactivity disorder (ADHD) by reproductive-age women is on the rise. [...]